These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 8704095)
1. Interleukin-1 and tumor necrosis factor-alpha in the Reed-Sternberg cells of Hodgkin's disease. Correlation with clinical and morphological "inflammatory" features. Benharroch D; Prinsloo I; Apte RN; Yermiahu T; Geffen DB; Yanai-Inbar I; Gopas J Eur Cytokine Netw; 1996; 7(1):51-7. PubMed ID: 8704095 [TBL] [Abstract][Full Text] [Related]
2. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study. Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619 [TBL] [Abstract][Full Text] [Related]
3. Reed-Sternberg cell: survival in a hostile sea. Cossman J; Messineo C; Bagg A Lab Invest; 1998 Mar; 78(3):229-35. PubMed ID: 9520936 [TBL] [Abstract][Full Text] [Related]
4. Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease. Tesch H; Günther A; Abts H; Jücker M; Klein S; Krueger GR; Diehl V Am J Pathol; 1993 Jun; 142(6):1714-20. PubMed ID: 8506943 [TBL] [Abstract][Full Text] [Related]
5. CD40 expression in Hodgkin's disease. O'Grady JT; Stewart S; Lowrey J; Howie SE; Krajewski AS Am J Pathol; 1994 Jan; 144(1):21-6. PubMed ID: 7507299 [TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma]. Müller H; Takeshita M; Krause J; Schuster K; Kikuchi M; Stutte HJ Verh Dtsch Ges Pathol; 1992; 76():164-8. PubMed ID: 1283251 [TBL] [Abstract][Full Text] [Related]
7. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation? Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270 [TBL] [Abstract][Full Text] [Related]
9. Expression of heat shock protein 70 (HSP70) and EBV latent membrane protein 1 (LMP1) in Reed-Sternberg cells of Hodgkin's disease. Takahashi H; Fujita S; Shibata Y; Tsuda N; Okabe H Anal Cell Pathol; 1996 Nov; 12(2):71-83. PubMed ID: 8986292 [TBL] [Abstract][Full Text] [Related]
10. Cytokine (interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6)-possessing cells in lymph nodes of malignant lymphoma. Takeshita M; Sumiyoshi Y; Masuda Y; Ohshima K; Yoshida T; Kikuchi M; Müller H Pathol Res Pract; 1993 Feb; 189(1):18-25. PubMed ID: 8516212 [TBL] [Abstract][Full Text] [Related]
11. Reed-Sternberg cells in the pathogenesis of Hodgkin's disease. Basić-Jukić N; Basić-Koretić M; Radman I; Labar B Acta Med Croatica; 2001; 55(3):115-21. PubMed ID: 11852730 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease. Hsu SM; Xie SS; Hsu PL; Waldron JA Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458 [TBL] [Abstract][Full Text] [Related]
14. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas. Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334 [TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma? Khan G Exp Hematol; 2006 Apr; 34(4):399-406. PubMed ID: 16569586 [TBL] [Abstract][Full Text] [Related]
16. Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease. Hsu SM; Lin J; Xie SS; Hsu PL; Rich S Hum Pathol; 1993 Mar; 24(3):249-55. PubMed ID: 7681031 [TBL] [Abstract][Full Text] [Related]
17. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells. Izban KF; Ergin M; Martinez RL; Alkan S Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929 [TBL] [Abstract][Full Text] [Related]
18. BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome. Rassidakis GZ; Medeiros LJ; McDonnell TJ; Viviani S; Bonfante V; Nadali G; Vassilakopoulos TP; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH Clin Cancer Res; 2002 Feb; 8(2):488-93. PubMed ID: 11839668 [TBL] [Abstract][Full Text] [Related]
19. [Morphology of histological subgroups of Hodgkin's disease (author's transl)]. Noltenius H; Prescher W Med Klin; 1977 Sep; 72(39):1579-85. PubMed ID: 916942 [TBL] [Abstract][Full Text] [Related]
20. Inflammatory myxohyaline tumor of distal extremities with virocyte or Reed-Sternberg-like cells: a distinctive lesion with features simulating inflammatory conditions, Hodgkin's disease, and various sarcomas. Montgomery EA; Devaney KO; Giordano TJ; Weiss SW Mod Pathol; 1998 Apr; 11(4):384-91. PubMed ID: 9578090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]